OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer-Reference-Cited by-同舟云学术

OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

Published:2023-05 Issue: Volume:184 Page:39-47
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Robson Mark E.^ORCID,Im Seock-Ah,Senkus Elzbieta,Xu Binghe,Domchek Susan M.,Masuda Norikazu,Delaloge Suzette,Tung Nadine,Armstrong Anne^ORCID,Dymond Mike^ORCID,Fielding Anitra,Allen Allison,Conte Pierfranco^ORCID

Funder

NCI

AstraZeneca PLC

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference11 articles.

1. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years;Malone;Cancer Res,2006

2. Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry;Kurian;Cancer Epidemiol Biomark Prev,2009

3. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic;Winter;Ann Oncol,2016

4. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer;Couch;J Clin Oncol,2015

5. Unique features of young age breast cancer and its management;Lee;J Breast Cancer,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review;Cancer Treatment Reviews;2024-11

2. BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs?;npj Breast Cancer;2024-09-05

3. BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing;British Journal of Cancer;2024-08-30

4. Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study;Cancers;2024-08-20

5. Leveraging PARP-1/2 to Target Distant Metastasis;International Journal of Molecular Sciences;2024-08-20